Markets:

Overview

News

Currencies

International

Treasuries

PerkinElmer (NY:PKI)

N/A UNCHANGED

Last Price Updated: 7:00 PM EDT, May 15, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about PerkinElmer

< Previous 1 2 3 4 5 6 Next >

PerkinElmer Q4 Sales Inch Up Marginally, Issues Q1 FY22 Guidance Ahead Of Consensus ↗

February 02, 2022

PerkinElmer Inc's (NYSE: PKI)

Via Benzinga

Recap: PerkinElmer Q4 Earnings ↗

February 01, 2022

PerkinElmer (NYSE:PKI) reported its Q4 earnings results on Tuesday, February 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2021

February 01, 2022

From PerkinElmer, Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

February 01, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

PerkinElmer Earnings Preview ↗

January 31, 2022

PerkinElmer (NYSE:PKI) is set to give its latest quarterly earnings report on Tuesday, 2022-02-01. Here's what investors need to know before the announcement. Analysts estimate that PerkinElmer will...

Via Benzinga

Watch for Continued Gains in Shares of PerkinElmer Inc. (PKI)

December 30, 2021

Via Investor Brand Network

Earnings Scheduled For November 2, 2021 ↗

November 02, 2021

Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion. •...

Via Benzinga

PerkinElmer Board Declares Quarterly Dividend

January 27, 2022

From PerkinElmer, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022 ↗

January 18, 2022

Upgrades Canaccord Genuity upgraded the previous rating for Fortuna Silver Mines Inc (NYSE:

Via Benzinga

26 Firms Going Ex-Dividend Next Week, Including CVS Health, APA Corp. And Procter & Gamble ↗

January 14, 2022

There are several well known large cap stocks going ex-dividend next week including 4 of our Top 100 Dividend Stocks.

Via Talk Markets

PerkinElmer Updates Fourth Quarter Outlook; To Hold Earnings Call on Tuesday, February 1, 2022

January 11, 2022

From PerkinElmer, Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

January 03, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...

Via Benzinga

Watch for Continued Gains in Shares of PerkinElmer Inc. ↗

December 30, 2021

PerkinElmer Inc. (NYSE: PKI) traded at a new 12-month high today of $199.57. Approximately 157,000 shares have changed hands today, as compared to an average 30-day volume of 1.1...

Via Benzinga

Free COVID Tests: What Stocks Will Benefit? ↗

December 23, 2021

The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits.

Via Talk Markets

PerkinElmer to Present Virtually at J.P. Morgan Healthcare Conference

December 21, 2021

From PerkinElmer, Inc.

Via Business Wire

Composite Rating For ICON Rises To 96; Awaits Breakout ↗

December 08, 2021

The IBD SmartSelect Composite Rating ICON stock rose from 94 to 96 Wednesday as the Ireland-based clinical researcher approaches a buy point.

Via Investor's Business Daily

PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 to Strengthen SARS-CoV-2 Surveillance

December 08, 2021

From PerkinElmer, Inc.

Via Business Wire

PerkinElmer Confirms That Omicron Variant Does Not Impact SARS-CoV-2 Detection Capability of its RT-PCR Assays

November 29, 2021

From PerkinElmer, Inc.

Via Business Wire

PerkinElmer to Present at Evercore ISI HealthCONx Conference 2021

November 16, 2021

From PerkinElmer, Inc.

Via Business Wire

Here's How Much $100 Invested In PerkinElmer 10 Years Ago Would Be Worth Today ↗

November 12, 2021

PerkinElmer (NYSE:PKI) has outperformed the market over the past 10 years by 11.05% on an annualized basis. Buying $100 In PKI: 10 years ago, an investor could have purchased 5....

Via Benzinga

PerkinElmer Stock, Already Highly Rated, Perks Up Further Amid Brisk Sales, Profit Growth For Its Instruments ↗

November 11, 2021

A Relative Strength Rating upgrade for PerkinElmer shows improving technical performance. Will it continue?

Via Investor's Business Daily

PerkinElmer, Inc (PKI) Q3 2021 Earnings Call Transcript ↗

November 06, 2021

PKI earnings call for the period ending October 30, 2021.

Via The Motley Fool

Topics Earnings

PerkinElmer to Present at 2021 Stifel Healthcare Conference

November 05, 2021

From PerkinElmer, Inc.

Via Business Wire

PerkinElmer Q3 Earnings, FY21 Guidance Beat Wall Street Expectations ↗

November 03, 2021

PerkinElmer Inc's (NYSE: PKI) Q3 revenues increased 21% Y/Y (12% organic) to $1.17 billion, beating the consensus of $1.04 billion. Diagnostics segment posted $654...

Via Benzinga

PerkinElmer: Q3 Earnings Insights ↗

November 02, 2021

PerkinElmer (NYSE:PKI) reported its Q3 earnings results on Tuesday, November 2, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Recap: PerkinElmer Q3 Earnings ↗

November 02, 2021

PerkinElmer (NYSE:PKI) reported its Q3 earnings results on Tuesday, November 2, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

PerkinElmer Announces Financial Results for the Third Quarter of 2021

November 02, 2021

From PerkinElmer, Inc.

Via Business Wire

PerkinElmer Releases 2021 Corporate Social Responsibility Report

November 01, 2021

From PerkinElmer, Inc.

Via Business Wire

PerkinElmer Board Declares Quarterly Dividend

October 27, 2021

From PerkinElmer, Inc.

Via Business Wire

PerkinElmer and Honeycomb Biotechnologies Launch the HIVE scRNAseq Solution for Single-Cell Analysis

October 18, 2021

From PerkinElmer, Inc. and Honeycomb Biotechnologies, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.